Characteristic | Calcification group (n = 200) | Noncalcification group (n = 24) | p |
---|---|---|---|
Age, yr | 71.98 ± 9.05 | 64.92 ± 12.29 | 0.009* |
Male | 164 (82.00) | 20 (83.33) | 0.872 |
Comorbidities | |||
 Hypertension | 159 (79.50) | 18 (75.00) | 0.609 |
 Diabetes | 65 (32.50) | 5 (20.83) | 0.244 |
 Coronary artery disease | 45 (22.50) | 2 (8.33) | 0.107 |
 Atrial fibrillation | 13 (6.50) | 0 (0.00) | 0.370 |
Laboratory data | |||
 Creatinine (umol/L) | 83.05 ± 28.95 | 73.65 ± 20.05 | 0.124 |
 GFR (mL/min/1.73m2) | 82.00 ± 22.50 | 92.45 ± 22.93 | 0.043* |
 blood sugar (mmol/L) | 6.47 ± 3.14 | 5.36 ± 1.49 | 0.203 |
 Calcium (mmol/L) | 2.22 ± 0.14 | 2.23 ± 0.11 | 0.898 |
 Phosphorus (mmol/L) | 1.09 ± 0.20 | 1.07 ± 0.13 | 0.350 |
 Triglyceride (mmol/L) | 1.41 ± 0.81 | 1.09 ± 0.20 | 0.164 |
 Cholesterol (mmol/L) | 4.03 ± 1.18 | 3.97 ± 0.93 | 0.796 |
 HDL (mmol/L) | 1.06 ± 0.28 | 1.11 ± 0.30 | 0.449 |
 LDL (mmol/L) | 2.43 ± 1.00 | 2.38 ± 0.84 | 0.802 |
Clinical data | |||
 Statin use | 48 (24.00) | 4 (16.67) | 0.421 |
 Antiplatelet use | 58 (29.00) | 6 (25.00) | 0.682 |
 Moderate stenosis | 113 (56.50) | 9 (37.50) | 0.077 |
 Left arterial stenosis | 102 (51.00) | 12 (50.00) | 0.926 |
 Ipsilateral symptom | 59 (29.50) | 12 (50.00) | 0.041* |